Novavax | DEFA14A: Others
Apr 29 20:03
Novavax | DEF 14A: Definitive information statements
Apr 29 19:57
Novavax | 8-K: Current report
Apr 27 04:39
Novavax | 8-K: Confidential Settlement Agreements and Release Agreements
Mar 27 04:07
Novavax | 8-K: Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Feb 28 21:12
Novavax | 8-K: Entry into a Termination and Settlement Agreement
Feb 22 19:11
Novavax | 8-K: Current report
Jan 31 21:01
Novavax | 8-K: Results of Operations and Financial Condition
Jan 8 13:00
Novavax | 8-K: Sothinathan Sinnathurai files alleged securities class action lawsuit against Novavax and certain members of the company's senior management
Dec 5, 2023 21:45
Novavax | 8-K: Novavax Executive Leadership Team Membership Changes
Nov 18, 2023 05:36
Novavax | 8-K: Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
Nov 9, 2023 21:05
Novavax | 8-K/A: Poll Results of 2023 Annual Meeting of Shareholders
Nov 3, 2023 05:00
Novavax | 8-K: Current report
Oct 4, 2023 04:59
Novavax | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 9, 2023 04:06
Novavax | 8-K: Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights
Aug 8, 2023 20:05
Novavax | 8-K: AT MARKET ISSUANCE SALES AGREEMENT
Aug 8, 2023 19:56
Novavax | 8-K: SECURITIES SUBSCRIPTION AGREEMENT
Aug 8, 2023 19:20
Novavax | 8-K: NOVAVAX, INC. 2015 STOCK INCENTIVE PLAN AMENDED AND RESTATED MARCH 30, 2023
Jul 12, 2023 05:12
Novavax | DEFA14A: Others
Jul 8, 2023 04:30
Novavax | 8-K: Entry into a Material Definitive Agreement
Jul 8, 2023 04:01
No Data
No Data